Creative Financial Designs Inc United Therapeutics Corp Transaction History

Creative Financial Designs Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 23, 2019	SELL	$107.15 - $126.84 $3,535 - $4,185	-33 Closed	0 $0
Q4 2018 Jan 24, 2019	SELL	$101.4 - $128.73 $3,447 - $4,376	-34 Reduced 50.75%	33 $4,000
Q3 2018 Nov 02, 2018	SELL	$113.81 - $129.46 $9,218 - $10,486	-81 Reduced 54.73%	67 $9,000
Q2 2018 Jul 13, 2018	BUY	$101.14 - $118.31 $14,968 - $17,509	148 New	148 $17,000

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Creative Financial Designs Inc , based on Form 13F filings with the SEC.

Stay updated on Creative Financial Designs Inc with notifications on news.